Regardless of their potential impact on patient health, drug approval times in Canada were longer than in other countries.
The province had the capacity to perform more than 1.3 million CT exams but only 419,000 were actually performed.
Hospitals currently view patients as costs that eat into the budget.
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
The elective surgery queue cost 1.2 million Canadians a total of $2.8 billion in lost wages and productivity.
If Moderna had been allowed to sell its vaccines earlier, many Canadian death and illnesses may have been prevented.
The provincial government contracted several private surgical clinics to help clear the backlog.
Premier Ford wants the federal government to cover 35 per cent of health-care costs, up from 22 per cent.
Last year, British Columbia became the first province to introduce a mandatory biosimilar switching program for non-medical reasons.
The estimated time to clear the backlog has been reduced from 24 months to 15 months.
Subscribe to the Fraser Institute
Get the latest news from the Fraser Institute on the latest research studies, news and events.